Abstract. The Na + /Mg 2+ exchanger SLC41A1 is involved in the pathophysiology of various disease conditions. It forms high-molecular-mass, possibly hetero-oligomeric protein complexes in transgenic HEK293 cells. Therefore, we attempted to identify binding partners of SLC41A1 by utilizing the split-ubiquitin modification of the yeast two-hybrid assay. As the most prominent binding partners in our experimental system, we identified 3-betahydroxysteroid-(8), (7)-isomerase and B-cell receptor associated-protein 31. Other polytons (interactors appearing in the screen more than once) included: IER3IP1, PPIB, UPF0480 protein C15orf24, SPINT2, C14orf1/PEBP28, NIFIE14, YIPF6, and KCP2. In total, 20 polytons and 38 singletons (interactors appearing in the screen only once) were identified. The polytons identified were mostly endoplasmic reticulum-located, integral proteins involved in protein maturation, N-glycosylation, protein folding, anterograde transport of proteins, protein secretion, and the regulation of apoptosis. Among the singletons, we identified SLC31A2, SLC35B1, SLC39A13, CRACM1, and MTCH2 as putative binding partners of SLC41A1. Interestingly, we did not identify interactions among SLC41A1 molecules. Most of the identified interactors are integral proteins localized in cellular compartments other than the cytoplasmic membrane, whereas SLC41A1 is targeted to the cytoplasmic membrane where it performs its core function. None of the interactors was confirmed by mass spectrometry. Instead, we identified among the proteins co-purified with strep-tagged SLC41A1: ACCA1, UBB, ATX2L, HSP7C and TBB.We therefore conclude that: (1) identified interactors form transient rather than stable complexes with SLC41A1, (2) the molecular interactors identified primarily among the polytons might contribute to the production, proper folding, and maturation of SLC41A1 in the endoplasmic reticulum and Golgi apparatus, (3) most of the interactors identified among singletons might undergo similar maturation steps (post-translational modification), anterograde transport, and protein sorting as SLC41A1.
SLC41A1, which has recently been characterized as being an Na + /Mg 2+ exchanger (NME), is a plasma membrane-localized protein shown to form protein complexes in vivo [1, 2] . NME has been proposed to be a key component of intracellular magnesium (Mg) homeostasis and the predominant Mg 2+ -efflux mechanism. The ubiquitous expression of SLC41A1 in mammalian cells further underlines its importance for the normal physiology of the cell. NME activity has been connected with many pathophysiological conditions over the years, including cardiovascular (myocardial infarction, ischemic heart disease, essential hypertension, pre-eclampsia/eclampsia), metabolic (diabetes mellitus type 2), psychiatric (ADHD syndrome), and neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD) [3] . In particular, an involvement of NME in the etiology of PD has been shown by recent findings demonstrating that SLC41A1 is part of the PD susceptibility locus PARK16 [4] [5] [6] [7] . Therefore, identification of the binding partners of SLC41A1 is a crucial step towards understanding the involvement of SLC41A1 in normal Mg 2+ homeostasis of the cell and its regulation, and also of the involvement of NME, and therefore, intracellular Mg 2+ homeostasis, in the pathophysiology of the aforementioned diseases.
Here, we decided to identify binding partners of SLC41A1 by utilizing a split-ubiquitin yeast two-hybrid assay (SU-YTH, [8] ), with the aim of clarifying the nature of the protein complexes seen in our previous study, and their physiological relevance (role in neogenesis, maturation, regulation of function, and/or degradation of SLC41A1). We have identified mostly proteins integral to membranes constituting the endoplasmic reticulum (ER) and Golgi apparatus (GA) and playing a role in proteoneogenesis, proper folding, maturation, secretion, anterograde transport, and the regulation of apoptosis. Among the binding partner candidates, we have also identified other members of the SLC superfamily involved in lysosomal Cu 2+ -, GA Zn 2+ -and ER sugar-transport. We therefore speculate that these proteins undergo similar modifications with regard to their maturation (post-translational modification in ER and GA) as SLC41A1.
Methods and materials
The split-ubiquitin yeast two hybrid assay [8] Briefly, the bait (SLC41A1) was PCR-amplified from pGEMT-SLC41A1 [2] . The product was inserted into vectors pBT3-STE and pBT3-N (both Dualsystems Biotech, Schlieren, Switzerland) via SfiI(A) and SfiI(B) restriction sites. Insertion led to the generation of a DNA template for the carboxy-terminal or amino-terminal fusion of SLC41A1 with the Cub-LexA-VP16 reporter cassette. The orientation and sequence of the inserts were verified by 5'-and 3'-end sequencing. Plasmids containing bait construct were inserted into Saccharomyces cerevisiae reporter strain NMY32 (Dualsystems Biotech) respectively, and co-expressed with several positive controls (yeast membrane proteins fused to NubI and NubG). Functional tests revealed that p-BT3-STE-SLC41A1 was better suited for downstream experimentation. A cDNA library derived from Jurkat T cells was cloned into pDSL-Nx (Dualsystems Biotech). The estimated complexity of the library was 9 × 10 6 and the average insert size was 1.5 kb. The library was inserted into strain NMY32 bearing the bait construct and yeasts were grown on SD-ade-his-leu-trp + 3-aminotriazole (1 mmol/L). 8.1 × 10 6 transformants were screened. The positivity of the selected clones was verified by the five-times passage in liquid selective medium. Moreover, the selected prey clones were further assayed for the activity of the second reporter gene, lacZ. Dual selection ensured specificity of the screen. Positive preys were sequenced and the sequences were translated in all three reading frames. Translated sequences were further blasted using BlastX (SwissProt) and their identities were revealed.
Affinity purification and Western blot analysis: protein expression, solubilization, and affinity purification: protein expression was induced by the addition of tetracycline (+tet 1 g/mL) for 24 hours. HEK293 cells over-expressing HA-streptagged SLC41A1, together with the uninduced control were lysed with RIPA buffer without SDS for 30 min under gentle agitation. After centrifugation to pellet unsolubilized debris, the 57 supernatant obtained was mixed with SDS sample buffer and loaded directly onto a 10% SDS polyacrylamide (PAA) gel. For strep-affinity purification, the cells were solubilized in affinity purification buffer (100 mmol/L Tris HCl pH 8, 150 mmol/L NaCl and 1.2% Triton X-100) supplemented with complete ultra protease inhibitor cocktail (Roche Diagnostics Deutschland GmbH, Mannheim, Germany). After centrifugation (14,000 rpm for 30 min), the supernatant was loaded onto a column packed with strep-Tactin resin (IBA, Göttingen, Germany). Following a washing step in the strep-affinity purification buffer with a reduced Triton-X100 concentration (0.2%), proteins bound to the column were eluted in the same buffer containing 2.5 mmol/L desthiobiotin. Eluted proteins were separated on a 10% SDS-polyacrylamide gel and transferred to a PVDF membrane. Immunoblotting was performed in TBS-TWEEN plus 2.5% dried milk with antibodies against the strep-tag (Qiagen, Hilden, Germany), EBP (emopamil binding protein) (Abcam, Cambridge, Great Britain), and RPL19 (ribosomal protein 19) (Abnova, Taipei City, Taiwan). Anti-mouse IgG linked to HRP (Cell Signalling Technology, Danvers, MA, USA) was used as the secondary antibody. Proteins were visualized by use of the SuperSignal TM West Pico system (Pierce/ Thermo Scientific, Rockford, IL, USA).
Mass Spectrometry
Affinity purification of strep-tagged SLC41A1 and of potential interaction partners from +tet cells (6 × 10 7 ) was performed as described previously. Proteins were precipitated with acetone; the pellet was dissolved in 2x SDS-loading dye and proteins were separated on an 8.5% SDS PAA gel and stained with colloidal Coomassie (Roti-Blue; Carl Roth GmbH, Karlsruhe, Germany) overnight. Peptides from gel-purified proteins were obtained by trypsin, in-gel digestion as described previously [9] , and peptide masses were analysed by matrixassisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS) using an Ultraflex-II TOF/TOF instrument (Bruker Daltonics, Fremont, CA USA) equipped with a 200 Hz solid-state Smart beam TM laser. The mass spectrometer was operated in the positive reflector mode. Mass spectra were acquired over an m/z range of 600 to 4000.
␣-cyano-4-hydroxycinnamic
acid (CHCA; Sigma-Aldrich, St. Louis, MO, USA) was used as the matrix, and protein digest samples were spotted using the dried droplet technique. MS/MS spectra of selected peptides were acquired in the LIFT mode [10] .
Database searches were performed using Mascot (Matrix Science Ltd., London, Great Britain; http://www.matrixscience.com). Mass tolerance was usually set at ± 75 ppm and we allowed for one missed cleavage.
Common chemicals were purchased from Carl Roth GmbH and Sigma-Aldrich.
Results and discussion
Results from the SU-YTH assay revealed, in total, 58 interactors of SLC41A1. Among these, 20 were polytons and 38 singletons. Five polytons and four singletons were excluded from the group of relevant SLC41A1-interactors, as they are found in the vast majority of DUALmembrane SU-YTH screens, and interactions between these proteins and SLC41A1 might not be relevant to the biological function of SLC41A1 (Dualsystems Biotech). The most prominent candidate, identified in 24 clones, was 3-beta-hydroxysteroid-(8), (7)-isomerase (also known as emopamil binding protein; EBP), an enzyme that catalyzes the conversion of (8)-sterols to their corresponding (7)-isomers (figure 1). It is a nonglycosylated type I integral membrane protein of the endoplasmic reticulum (ER) possessing four putative transmembrane domains and showing high levels of expression in epithelial tissues [11, 12] . Defects in EBP are the cause of X-linked dominant chondrodysplasia punctata, also known as Conradi-Hünermann-Happle syndrome, which can be considered as a phenocopy of warfarin embryopathy [13, 14] . A protein-protein interaction between EBP and the vitamin K epoxide reductase complex subunit 1 (VKORC1) has been demonstrated by Schaafhausen and colleagues [14] .
Next, we wondered whether we could isolate HA-strep-SLC41A1:EBP complexes by affinity purification from the native RIPA total protein lysate obtained from transgenic tetracyclineinduced (24h) HEK293-(HA-strep-SLC41A1). RIPA lysate (native) and proteins bound to the strep-column were eluted and separated on a 58 SLC41A1 forms a wide range of transient complexes in vivo Immediate early-response 3-interacting protein 1
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S (1) S (1) S (1) S (1) S (1) S (1) S (1) S (1) S (1) S ( 10% PAA-SDS gel and analyzed by immunoblotting. Figure 2A shows the membrane incubated with an antibody against the strep-tag (∼56 kDa). HA-strep-SLC41A1-specific bands were detected in both the RIPA lysate and the strepaffinity-purified fraction. The specificity of the strep-affinity purification was controlled by the detection of RPL19 (∼25kDa), which was present exclusively in the total lysate, but not in the affinity-purified fraction ( figure 2A) . Figure 2B depicts immunodetection performed with an antibody against EBP. After extensive washing, the same membrane was reincubated with an antibody directed against RPL19 ( figure 2C ). Figure 2 . Western blot detection of EBP in the affinity-purified strep-SLC41A1 fraction. RIPA (no SDS) lysates and strep-affinity-purified fractions isolated from induced (+) and uninduced (-) HEK293-(HA-strep-SLC41A1) were resolved on 10% SDS polyacrylamide gel. As it is shown in (A), the strep-SLC41A1-specific signal was detected in RIPA lysate and strep-purified fraction isolated from + cells, and due to leaky expression, also from -cells (but in significantly lesser quantities). The EBP-specific signal was detected exclusively in RIPA lysates isolated from both, +
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and -cells (B). No EBP was detected in strep-purified fractions isolated either from + cells or -cells (B). RPL19 was used to control specificity of purification and as a loading control (A, C).
Obviously, EBP was not present in the strepaffinity-purified fraction. Therefore, we assume that EBP and SLC41A1 do not form a stable protein complex. Ten clones (figure 1) revealed an interaction between SLC41A1 and B-cell receptor associated-protein 31 (BAP31). Human BAP31 is a 246-amino-acid type III transmembrane protein located in the ER and consists of three transmembrane domains [15] . It plays a role in the anterograde transport of membrane proteins from ER to downstream compartments of the secretory pathway, e.g., GA [16] . It might also be involved in CASP8-mediated apoptosis [17, 18] . It forms homodimers and/or heterodimers with BAP29. BAP31 also interacts with mIgD, cellubrevin, major histocompatibility complex class I, BCL-2/BCL-X(L) [16] , and protein tyrosine phosphatase-like member B [19] . Loss of function of BAP31 has recently been proposed to be related to liver dysfunction and hearing loss [20] . BAP31 is deleted in chromosome Xq28 deletion syndrome, which involves BAP31 and the promoter region of ABCD1 [21] .
The third strongest SLC41A1-binding candidates were peptidyl-prolyl cis-trans isomerase (PPIB), and a predicted single-pass type I membrane protein of unknown function (membranome.org; UniProt) UPF0480 protein C15orf24 ( figure 1) . Homology analyses revealed that PPIB is a member of the cyclophilin B family, which is distinguished from the cyclophilin A family by the presence of an ER-targeting signal sequence. PPIB (soluble enzyme; SOSUI engine v.1.11) accelerates the folding of proteins by catalyzing the cis-trans isomerization of proline imidic peptide bonds in oligopeptides (UniProt). Its enzymatic activity can be inhibited by cyclosporin A [22] . PPIB has been shown to interact with dymeclin (DYM) protein, which is known to cause Dyggve-Melchior-Clausen syndrome (a disorder of the skeletal development combined with mental retardation) when mutated [23] . Defects in PPIB are the cause of a connective tissue disorder called osteogenesis imperfecta type 9 [24] .
The other identified polytons were (figure 1): immediate early-response 3-interacting protein (IER3IP1), Kunitz type protease inhibitor 2 (SPINT2), protein YIPF6, keratinocyte-associated protein 2 (KCP2), probable ergosterol biosynthetic protein 28 (C14orf1/PEBP28), transmembrane protein 147 (NIFIE14), putative protein CXorf62, uncharacterized protein C10orf35, uncharacterized protein C4orf3, transmembrane protein 147, and transmembrane protein 14A.
IER3IP1 encodes an ER-localized integral protein possessing a G-patch domain (suggested to be involved in RNA binding) and a C-terminal transmembrane domain [25] . It is highly expressed in heart, skeletal muscle, kidney, and moderately expressed in liver and brain, with low expression being detected in placenta, lung, and peripheral blood leukocytes [25] . IER31P1 has been shown to be involved in the regulation of cell survival. It has an impact on brain development, and when mutated, it is involved in the pathogenesis of infantile epilepsy and early-onset permanent diabetes [26] .
SPINT2 is a transmembrane protein with two extracellular Kunitz domains that inhibits a variety of serineproteases (GeneCards.org, [27] ). When nonfunctional, it causes congenital secretory sodium diarrhea type 3, which is a rare inherited diarrhea of infancy [28] , and possibly also syndromic tufting enteropathy [29] . Kongkham and colleagues [30] have identified SPINT2 as a putative tumor suppressor gene in pediatric medulloblastoma.
YIPF6 belongs to the YIP1 family. It is a five transmembrane-spanning protein associated with Golgi compartments [31] . Yip1p and Yif1p have been proposed to play a critical role in establishing the fusion competence of ER to Golgi vesicles at the time of budding in Saccharomyces cerevisiae. Moreover, the Yip1p:Yif1p complex binds to the ER and to Golgi SNAREs Bos1p and Sec22p, two components of the membrane fusion machinery [32] . YIPF6 mutation induces spontaneous intestinal inflammation in mice [31] .
Roboti and High [33] have demonstrated, by native gel analysis, that the majority of KCP2 assembles into a distinct ∼500 kDa complex also containing several bona fide oligosaccharyltransferase (OST) subunits (STT3A, STT3B, and OST48). Therefore, KCP2 is concluded to be a newly identified subunit of the N-glycosylation machinery present in eukaryotes [34] . OST, an integral membrane protein complex active on the luminal side of the ER, catalyzes N-glycosylation, the process of transfer of a high-mannose oligosaccharide to asparagines in selected glycosylation sequons (N-X-S/T) of nascent polypeptide chains [35] .
NIFIE14 is an ER-localized integral protein with a putative topology similar to APH-1. Dettmer and colleagues [36] have concluded that it is a novel core component of the Nicalin-NOMO complex, therefore emphasizing its similarity with gamma-secretase, which catalyzes the proteolytic cleavage of the transmembrane domain of various proteins.
The remaining polytons were represented by molecularly and functionally uncharacterized proteins. Interesting binding partner candidates identified among singletons were: probable low affinity Cu 2+ uptake protein 2 (SLC31A2), an oligomeric membrane protein that is localized in lysosomes and that stimulates copper delivery to the cytosol of human cells at relatively high copper concentrations [37] ; mitochondrial carrier homologue 2 (MTCH2), which is a transporter of unknown solute and integral to the inner mitochondrial membrane; Ca 2+ -release-activated Ca 2+ channel protein 1 (CRACM1; also known as ORAI1), a plasma-membrane-localized protein essential for store-operated Ca 2+ entry [38, 39] ; Zn 2+ transporter ZIP13 (SLC39A13) [40] , an integral protein of GA; and solute carrier family 35 member B1 (SLC35B1), which is probably an ERlocated sugar transporter (UniProt).
Interestingly, we have not identified clones in which SLC41A1 "prey" binds SLC41A1 "bait" indicating that SLC41A1 does not form homooligomeric complexes in mammalian cells and in agreement with our previously published conclusion that SLC41A1 forms hetero-oligomeric complexes in mammalian cells [2] .
As we have also previously identified SLC41A1 complexes with molecular weights ranging between 700 and 1000 kDa, we speculated that SLC41A1 forms complexes with the cytoskeleton and/or its components, such as the large anchoring molecules of the cytoskeleton [2] . However, among the SLC41A1 binding-partner candidates, we did not identify any such components.
Goytain and Quamme [41] have proposed N-glycosylation as being a possible posttranslational modification of SLC41A1. Indeed, computer prediction has revealed four putative glycosylation sequons within the sequence of SLC41A1 (NetNGlyc 1.0 Server; DTU). However, three are located within the N-terminal cytoplasmic domain [2] , and only the fourth is positioned in the putative extracellular loop domain (aa 463 -aa 483 ; TMpred at ch.EMBnet.org). Therefore, the identification of KCP2 (a component of oligosaccharyltransferase) among putative SLC41A1 binding partners (polytons) further supports the assumption of Goytain and Quamme [41] and underlines N-glycosylation as a possible post-translational modification of SLC41A1.
Next we performed MALDI-TOF-MS analysis of in gel trypsin-digested proteins [42] . These resulted from SDS polyacrylamide electroseparation of affinity-purified strep-tagged SLC41A1 and of potential interaction partners ( figure 3) . Mass spectrometry revealed in a band with molecular mass > 170 kDa SLC41A1, acetyl-CoA-carboxylase 1 (ACCA1) and ubiquitin (polyubiquitin); in a band with molecular mass ∼130 kDa ataxin-2-like protein (ATX2L); in a band with molecular mass ∼70 kDa heat shock cognate protein 71 (HSP7C); and in a band with molecular mass ∼55 kDa SLC41A1 and tubulin-␤-chain (TBB). None of them was identified as being an interactor in the functional SU-YTH assay. We therefore assume that these proteins most probably do not form stable (functional) complexes with SLC41A1 in vivo. However, an exception might be ACCA1 and ubiquitin as both were found in a band together with SLC41A1 (56 kDa when monomeric) with a molecular mass well over > 170 kDa (the highest molecular mass band of the protein marker we used). This would mean that SLC41A1 forms a complex with ACCA1 stable enough to co-purify with strep-tagged SLC41A1. ACCA1 [43] . ACCA1 is a rate-limiting, biotindependent enzyme of the de novo synthesis of long-chain fatty acids, catalyzing the formation of malonyl-CoA by ATP-dependent carboxylation of acetyl-CoA [43] . It is located and functionally active in cytoplasm (UniProt).
Conclusions
By employing an SU-YTH assay, we have confirmed the complex-forming ability of SLC41A1. Twenty polytons and 38 singletons were identified as potential binding-partners of SLC41A1. The proteins identified among the polytons were mostly ER-and/or GA-localized proteins involved in proteoneogenesis, proper folding, and maturation (post-translational modifications) of proteins. At present, we are unable to suggest the possible physiological relevance of the transient interaction between EBP (the most prominent interactor in our screen) and SLC41A1. Therefore, further experiments studying the effects of the inhibition of EBP enzymatic activity and of the silencing of EBP transcription activity on SLC41A1 function will be necessary to establish any functional link between these two proteins. Among singletons, we have identified (in addition to ERand GA-located proteins) nuclear-membrane-and plasma-membrane-localized proteins of unclear functional relevance to SLC41A1, other members of the SLC superfamily, and other solute transport mechanisms. Interactions between these and SLC41A1 can be explained as being transient and provoked by common pathways of their maturation in ER and/or GA and/or vesicular transport. MALDI-TOF-MS revealed an interesting putative interactor of SLC41A1, ACCA1. Its interaction with SLC41A1 should be studied further, since todate, no obvious functional relationship between them has been reported.
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